Can Nitric Oxide-Based Therapy Prevent Bronchopulmonary Dysplasia?

被引:9
作者
Raffay, Thomas M. [1 ]
Martin, Richard J. [1 ]
Reynolds, James D. [2 ,3 ]
机构
[1] Univ Hosp Cleveland, Rainbow Babies & Childrens Hosp, Dept Pediat, Div Neonatol,Case Med Ctr, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Inst Transformat Mol Med, Cleveland, OH 44106 USA
[3] Univ Hosp Cleveland, Dept Anesthesia & Perioperat Med, Case Med Ctr, Cleveland, OH 44106 USA
关键词
Inhaled nitric oxide (iNO); Bronchopulmonary dysplasia (BPD); Neonate; Prematurity; S-nitrosylation; S-nitrosothiol (SNO); Ethyl nitrite (ENO); PERSISTENT PULMONARY-HYPERTENSION; RANDOMIZED CONTROLLED-TRIAL; CHRONIC LUNG-DISEASE; SEVERE RESPIRATORY-FAILURE; ENDOTHELIAL GROWTH-FACTOR; RED-BLOOD-CELLS; NF-KAPPA-B; RISK PRETERM INFANTS; SMOOTH-MUSCLE-CELLS; S-NITROSYLATION;
D O I
10.1016/j.clp.2012.06.011
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
A growing understanding of endogenous nitric oxide (NO) biology is helping to explain how and when exogenous NO may confer benefit or harm; this knowledge is also helping to identify new better-targeted NO-based therapies. In this review, results of the bronchopulmonary dysplasia clinical trials that used inhaled NO in the preterm population are placed in context, the biologic basis for novel NO therapeutics is considered, and possible future directions for NO-focused clinical and basic research in developmental lung disease are identified.
引用
收藏
页码:613 / +
页数:27
相关论文
共 50 条
  • [31] Variation in the Use of Diuretic Therapy for Infants With Bronchopulmonary Dysplasia
    Slaughter, Jonathan L.
    Stenger, Michael R.
    Reagan, Patricia B.
    PEDIATRICS, 2013, 131 (04) : 716 - 723
  • [32] Cell Therapy: A Novel Treatment Approach for Bronchopulmonary Dysplasia
    Vosdoganes, Patricia
    Lim, Rebecca
    Moss, Timothy J. M.
    Wallace, Euan M.
    PEDIATRICS, 2012, 130 (04) : 727 - 737
  • [33] Effects of Intravitreal Anti-VEGF Therapy on the Clinical Course of Bronchopulmonary Dysplasia
    Ovali, Fahri
    Yetik, Huseyin
    Tuten, Abdulhamit
    Topcuoglu, Sevilay
    Gunay, Murat
    IRANIAN JOURNAL OF PEDIATRICS, 2016, 26 (06)
  • [34] Long-term effects of postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia: Balancing the risks and benefits
    Cheong, Jeanie Ling Yoong
    Doyle, Lex William
    SEMINARS IN FETAL & NEONATAL MEDICINE, 2019, 24 (03) : 197 - 201
  • [35] Drugs to Prevent Bronchopulmonary Dysplasia: Effect of Baseline Risk on the Number Needed to Treat
    Jensen, Erik A.
    Roberts, Robin S.
    Schmidt, Barbara
    JOURNAL OF PEDIATRICS, 2020, 222 : 244 - 247
  • [36] Bronchopulmonary Dysplasia - Acute and Long Term Management to Prevent Chronic Lung Disease
    Voynow, Judith A.
    Kendig, Edwin L., Jr.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S83 - S84
  • [37] Prophylactic sildenafil to prevent bronchopulmonary dysplasia: A systematic review and meta-analysis
    Hirata, Katsuya
    Nakahari, Atsuko
    Takeoka, Mami
    Watanabe, Masahiko
    Nishimura, Yutaka
    Katayama, Yoshinori
    Isayama, Tetsuya
    PEDIATRICS INTERNATIONAL, 2024, 66 (01)
  • [38] Bronchopulmonary dysplasia and early prophylactic inhaled nitric oxide in preterm infants: current concepts and future research strategies in animal models
    Rieger-Fackeldey, Esther
    Hentschel, Roland
    JOURNAL OF PERINATAL MEDICINE, 2008, 36 (05) : 442 - 447
  • [39] Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan
    Onland, Wes
    Merkus, Maruschka P.
    Nuytemans, Debbie H.
    Jansen-van der Weide, Marijke C.
    Holman, Rebecca
    van Kaam, Anton H.
    TRIALS, 2018, 19
  • [40] Impact of Diuretic Therapy in the Treatment of Bronchopulmonary Dysplasia and Acute Kidney Injury in the Neonatal Population
    Johnson, Alexandra Kesler
    Lynch, Natalie
    Newberry, Desi
    Jnah, Amy J.
    ADVANCES IN NEONATAL CARE, 2017, 17 (05) : 337 - 346